Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Technologies that can pull tumor cells from patients’ blood are giving researchers an unprecedented look at cancer.
Genomics signatures in uterine cancers could offer clues to prognosis.
The impending Supreme Court ruling on gene patents is creating uncertainty in the molecular diagnostics sector.
Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.
Oxford Nanopore’s approach reads longer stretches of DNA at once—and could more accurately spot structural variations linked to certain diseases.
Tumors closer to committing “cellular suicide” are more sensitive to conventional anticancer drugs.
Researchers show that a smart phone can measure some vital signs accurately and conveniently.
The findings demonstrate how genome analysis could guide health-care decisions for healthy people.
Researchers are developing more and more genetic tests for specific cancers, but doctors don’t use them as often as they should—a new network of clinics aims to change that.